FDA Approves First Digital Pill: Otsuka/Proteus' Abilify MyCite
Executive Summary
Otsuka plans a slow, measured launch of Abilify MyCite, developed with Proteus Health. The product includes an ingested sensor that sends a signal to a wearable patch and an app that tracks ingestion, activity and mood to potentially improve management of psychiatric care.
You may also be interested in...
Keeping Track: A Second Straight Burst Of FDA Approvals
The latest drug approval and development news from our US FDA Performance Tracker.
FDA's NDA And BLA Approvals: Abilify Mycite, Mepsevii, Hemlibra
Original new drugs and biologics recently approved by US FDA.
FDA Ushers In Era of New Drug Manufacturing Technologies
FDA's Emerging Technology Team is guiding a diverse array of new manufacturing technologies through the agency's regulatory review process that could add market niches and possibly even fundamentally restructure the pharmaceutical industry.